Recurrent Pregnancy Loss in West Bengal: Causes, Diagnosis & Treatment Options

Recurrent Pregnancy Loss is not simply 'bad luck.' The Royal College of Obstetricians and Gynaecologists (RCOG) and the European Society of Human Reproduction and Embryology (ESHRE) both define RPL as two or more clinical pregnancy losses, although many Indian specialists — including the HomeIVF Medical Board — recommend initiating investigations after two consecutive losses, especially in women over 35.

A clinical pregnancy loss is distinct from a biochemical pregnancy loss: it refers to a pregnancy confirmed by ultrasound or histopathology, not merely a positive hPCG test that fades. This distinction matters enormously for West Bengal patients, as many women dismiss early losses as 'irregular periods' and never report them to a specialist.

RPL is classified as primary (no live birth prior to the losses) or secondary (losses occurring after at least one successful delivery). Secondary RPL can feel particularly confusing for couples in Kolkata or Howrah who have already experienced a successful pregnancy and assume the problem has resolved. Understanding the clinical framework is the first step toward targeted, effective care rather than repeated empirical treatments that offer no real benefit.

The causes of RPL are multifactorial, and identifying them requires a systematic workup rather than guesswork. Chromosomal abnormalities in the embryo — particularly aneuploidies — are the single most common cause, accounting for 50–60% of first-trimester losses. These are often random events, but parental chromosomal rearrangements such as balanced translocations can increase their frequency significantly.

Thrombophilic disorders, most notably Antiphospholipid Syndrome (APS), are found in 10–15% of RPL patients. APS causes abnormal clotting in placental blood vessels, starving the embryo of nutrients and oxygen. In West Bengal's population, where consanguineous marriages are more prevalent in certain communities, inherited thrombophilias such as Factor V Leiden and MTHFR mutations deserve particular attention.

Uterine structural anomalies — including septate uterus, submucosal fibroids, and intrauterine adhesions (Asherman's syndrome) — account for roughly 10–15% of cases and are often missed without a 3D ultrasound or hysteroscopy. Endocrine causes such as poorly controlled hypothyroidism (notably common in West Bengal due to dietary iodine patterns), undiagnosed PCOS, and elevated prolactin are also frequent contributors. Immunological factors and male factor DNA fragmentation round out the picture for many couples in Durgapur and Siliguri who have struggled for years without a clear answer.

The most obvious sign of RPL is the pattern itself — two or more pregnancy losses. However, certain additional symptoms may signal an underlying condition that warrants earlier investigation.

Vaginal bleeding or spotting in the first trimester, particularly if it has occurred across multiple pregnancies, is a red flag. So is a history of late-period bleeding that may actually represent unrecognised early chemical pregnancies. Women with irregular cycles, heavy menstrual bleeding, or known thyroid disorders who experience even a single pregnancy loss should discuss earlier RPL screening with a specialist.

For couples in Kolkata or Howrah with a known family history of clotting disorders, autoimmune diseases like lupus, or chromosomal conditions, proactive RPL testing is advisable before attempting another conception. Male partners should not be overlooked: elevated sperm DNA fragmentation — measurable through a sperm DNA fragmentation index (DFI) test — has been associated with increased miscarriage rates and is an underappreciated factor in RPL workups across Indian clinics.

If you have experienced recurrent losses and your current doctor has not recommended a structured diagnostic protocol, that is a signal to seek a second opinion. The HomeIVF Medical Board advises initiating a full RPL panel after two consecutive losses rather than waiting for a third.

A thorough RPL workup involves multiple specialties and several targeted investigations. The HomeIVF Medical Board follows an evidence-based protocol aligned with ESHRE 2023 guidelines, ensuring West Bengal patients receive globally benchmarked diagnostics.

The core panel includes: parental karyotyping (chromosomal analysis of both partners), antiphospholipid antibody panel (anticardiolipin antibodies, anti-β2 glycoprotein I, lupus anticoagulant), thrombophilia screening (MTHFR, Factor V Leiden, Protein C & S, antithrombin III), hormonal evaluation (TSH, free T4, prolactin, AMH, fasting insulin, Day-2 FSH/LH), and uterine assessment via 3D transvaginal ultrasound and, where indicated, saline infusion sonography or hysteroscopy.

HomeIVF coordinates home-based blood collection for most blood tests, removing the need for women in Siliguri or Durgapur to travel to centralised labs. Karyotyping samples are dispatched via certified cold-chain logistics to accredited genetic labs. Imaging is facilitated through HomeIVF's partnered diagnostic network across West Bengal. Results are reviewed by the HomeIVF Medical Board, who then prepare a structured case report — not merely a set of lab values — with clear clinical implications and recommended next steps, all shared through the HomeIVF app.

Treatment for RPL is cause-specific, which is exactly why diagnosis must precede treatment. Generic supplementation without investigation is both wasteful and potentially harmful.

For APS, the combination of low-dose aspirin and low-molecular-weight heparin (LMWH) has strong evidence, reducing pregnancy loss rates significantly in affected women. HomeIVF specialists supervise these protocols with monitoring visits coordinated at home or at local partner clinics in Kolkata and Howrah.

For thyroid dysfunction, optimising TSH to below 2.5 mIU/L before conception has been shown to improve outcomes. For uterine anomalies, operative hysteroscopy — such as septum resection or adhesiolysis — is referred to accredited centres within HomeIVF's West Bengal surgical network.

For couples with parental chromosomal rearrangements or advanced maternal age, IVF combined with Preimplantation Genetic Testing for Aneuploidies (PGT-A) offers the most evidence-backed path to a healthy live birth. IVF packages at HomeIVF start from ₹1.5 lakh, making this option far more accessible to families across West Bengal than traditional hospital pricing structures.

For elevated sperm DNA fragmentation, antioxidant therapy, lifestyle intervention, and in severe cases, testicular sperm extraction (TESA) with ICSI, are considered. Immunological RPL is treated with protocols such as intralipid infusions or lymphocyte immunotherapy where evidence supports their use.

Managing RPL requires sustained monitoring — hormone levels, pregnancy viability scans, and medication titration — that traditionally demands frequent clinic visits. For women in districts like Bardhaman, Jalpaiguri, or North 24 Parganas, travelling to Kolkata's specialist fertility clinics for every follow-up is financially draining and emotionally exhausting.

HomeIVF's home-monitoring model is specifically designed for this challenge. A trained HomeIVF coordinator conducts blood draws and vital sign assessments at the patient's home on scheduled dates. Results feed directly into the HomeIVF platform, where the Medical Board reviews them and updates medication instructions within 24 hours. Early viability scans are coordinated with the nearest accredited sonography centre in the patient's locality, with the scan report uploaded to the patient's HomeIVF digital file.

This continuity of care — without the anxiety of crowded OPD waiting rooms — has significant psychological value for RPL patients, who are at elevated risk for pregnancy-related anxiety and depression. HomeIVF's care model does not replace senior specialists; it delivers senior-specialist-level oversight in a more compassionate, patient-centred format. For working women in Siliguri or Durgapur balancing professional commitments with fertility treatment, this flexibility is genuinely life-changing.

West Bengal presents a distinct set of barriers for RPL patients that HomeIVF is specifically structured to address.

First, there is the specialist gap. While Kolkata hosts several large fertility centres, patients in Howrah, Asansol, Malda, or Cooch Behar often have no local access to RPL-trained reproductive medicine specialists. HomeIVF closes this gap through teleconsultation with senior specialists and a coordinated home-visit model.

Second, there is the stigma barrier. In many communities across West Bengal, repeated pregnancy loss is attributed to spiritual causes or personal fault, deterring women from seeking medical help. HomeIVF's discreet, home-based model allows couples to begin their diagnostic journey privately, without community scrutiny.

Third, diagnostic fragmentation is a serious issue: patients often consult a gynaecologist for the loss, a haematologist for clotting tests, and an endocrinologist for thyroid issues — with no single specialist integrating the findings. The HomeIVF Medical Board functions as a multidisciplinary team that synthesises all test results into a single, coherent treatment plan.

Finally, follow-up consistency is poor when travel is burdensome. HomeIVF's app-based tracking, home blood collection, and 24-hour medical query response system ensure that West Bengal patients remain engaged and adherent to their treatment protocols from first consultation through to a confirmed healthy pregnancy.

While HomeIVF does not publish individual patient stories without consent, the HomeIVF Medical Board has documented recurring patterns of successful RPL resolution that reflect the lived experience of West Bengal couples.

A typical archetype: a couple from Kolkata in their early thirties with three consecutive first-trimester losses and no prior investigation. Full RPL workup reveals APS in the female partner and a low-grade MTHFR heterozygous mutation. Treatment with low-dose aspirin, LMWH from the luteal phase, and folate supplementation results in a successful live birth within two subsequent conception cycles.

Another pattern: a woman from Siliguri, age 38, with two losses and a septa detected on 3D ultrasound. Hysteroscopic septum resection followed by a HomeIVF-supervised frozen embryo transfer cycle with luteal support produces a successful ongoing pregnancy.

A third archetype: a Durgapur couple where the male partner's sperm DNA fragmentation index was 34% (above the clinical threshold of 25%). Antioxidant protocol for three months, combined with lifestyle changes, reduced DFI to 18%, and a natural conception cycle succeeded. These patterns underscore a critical message: RPL is not a sentence. With systematic investigation and personalised care, the majority of couples achieve a live birth.